Gerard Aurigemma to Time Factors
This is a "connection" page, showing publications Gerard Aurigemma has written about Time Factors.
Connection Strength
0.262
-
Aurigemma GP, Keaney JF. Renin-angiotensin system inhibition for aortic stenosis "A II, Brut??". J Am Coll Cardiol. 2011 Aug 02; 58(6):577-80.
Score: 0.053
-
Botkin NF, Seth PS, Aurigemma GP. Asymptomatic valvular disease: who benefits from surgery? Curr Cardiol Rep. 2005 Mar; 7(2):87-93.
Score: 0.034
-
Vinch CS, Rashkin J, Logsetty G, Tighe DA, Hill JC, Meyer TE, Rosenthal LS, Aurigemma GP. Brain natriuretic peptide levels fall rapidly after cardioversion of atrial fibrillation to sinus rhythm. Cardiology. 2004; 102(4):188-93.
Score: 0.033
-
Upadhya B, Willard JJ, Lovato LC, Rocco MV, Lewis CE, Oparil S, Cushman WC, Bates JT, Bello NA, Aurigemma G, Johnson KC, Rodriguez CJ, Raj DS, Rastogi A, Tamariz L, Wiggers A, Kitzman DW. Incidence and Outcomes of Acute Heart Failure With Preserved Versus Reduced Ejection Fraction in SPRINT. Circ Heart Fail. 2021 12; 14(12):e008322.
Score: 0.027
-
Hendrix RJ, Bello RA, Flahive JM, Kakouros N, Aurigemma GP, Keaney JF, Hoffman W, Vassileva CM. Mitral Valve Repair Versus Replacement in Elderly With Degenerative Disease: Analysis of the STS Adult Cardiac Surgery?Database. Ann Thorac Surg. 2019 03; 107(3):747-753.
Score: 0.022
-
Upadhya B, Rocco M, Lewis CE, Oparil S, Lovato LC, Cushman WC, Bates JT, Bello NA, Aurigemma G, Fine LJ, Johnson KC, Rodriguez CJ, Raj DS, Rastogi A, Tamariz L, Wiggers A, Kitzman DW. Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial. Circ Heart Fail. 2017 Apr; 10(4).
Score: 0.020
-
Sardana M, Ogunsua AA, Spring M, Shaikh A, Asamoah O, Stokken G, Browning C, Ennis C, Donahue JK, Rosenthal LS, Floyd KC, Aurigemma GP, Parikh NI, McManus DD. Association of Left Atrial Function Index With Late Atrial Fibrillation Recurrence after Catheter Ablation. J Cardiovasc Electrophysiol. 2016 12; 27(12):1411-1419.
Score: 0.019
-
Wachtell K, Gerdts E, Palmieri V, Olsen MH, Nieminen MS, Papademetriou V, Boman K, Dahl?f B, Aurigemma GP, Rokkedal JE, Devereux RB. In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study. J Hypertens. 2010 Jul; 28(7):1541-6.
Score: 0.012
-
Aurigemma GP, Reichek N, Axel L, Schiebler M, Harris C, Kressel HY. Noninvasive determination of coronary artery bypass graft patency by cine magnetic resonance imaging. Circulation. 1989 Dec; 80(6):1595-602.
Score: 0.012
-
Fitzgibbons TP, Madias C, Seth A, Bouchard JL, Kuvin JT, Patel AR, Pandian NG, Meyer TE, Aurigemma GP, Tighe DA. Prevalence and clinical characteristics of right ventricular dysfunction in transient stress cardiomyopathy. Am J Cardiol. 2009 Jul 01; 104(1):133-6.
Score: 0.011
-
Liao L, Anstrom KJ, Gottdiener JS, Pappas PA, Whellan DJ, Kitzman DW, Aurigemma GP, Mark DB, Schulman KA, Jollis JG. Long-term costs and resource use in elderly participants with congestive heart failure in the Cardiovascular Health Study. Am Heart J. 2007 Feb; 153(2):245-52.
Score: 0.010
-
Litwin SE, Katz SE, Weinberg EO, Lorell BH, Aurigemma GP, Douglas PS. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation. 1995 May 15; 91(10):2642-54.
Score: 0.004
-
Zimrin D, Reichek N, Bogin KT, Aurigemma G, Douglas P, Berko B, Fung HL. Antianginal effects of intravenous nitroglycerin over 24 hours. Circulation. 1988 Jun; 77(6):1376-84.
Score: 0.003